Inventor · disambiguated record
Patrick Chames
Also filed as: CHAMES PATRICK · CHAMES PATRICK J M
14 granted patents·13 pending applications·94 citations·filing 2003–2023
90Inventor score
Top patents by PatentIndex Score
27 records- 0195US7842489B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS·Filed 2010·Granted Nov 30, 2010·63 cites·7 claims
- 0291US8530214B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2011·Granted Sep 10, 2013·13 cites·16 claims
- 0383US8624000B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2012·Granted Jan 7, 2014·5 cites·14 claims
- 0482US8697395B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2012·Granted Apr 15, 2014·4 cites·18 claims
- 0570US8206965B2Hybrid and single chain meganucleases and use thereofARNOULD SYLVAIN·Filed 2003·Granted Jun 26, 2012·6 cites·15 claims
- 0668US9512203B2Single-domain antibodies that bind to HIV-1 Nef with high affinityBATY DANIEL·Filed 2008·Granted Dec 6, 2016·3 cites·10 claims
- 0765US2019249170A1Methods for selecting binders by phage display and masked selectionINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0863US10316315B2Methods for selecting binders by phage display and masked selectionINST NAT SANTE RECH MED·Filed 2017·Granted Jun 11, 2019·0 cites·2 claims
- 0963US9605257B2Methods for selecting binders by phage display and masked selectionINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2013·Granted Mar 28, 2017·0 cites·1 claims
- 1062US2014121115A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2012·Application pending·0 cites
- 1162US2013203840A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS SA·Filed 2012·Application pending·0 cites
- 1260US2019202932A1Anti- egfr conformational single domain antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1358US2011151539A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2011·Application pending·0 cites
- 1457US2012159659A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2010·Application pending·0 cites
- 1557US2006153826A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 1657US2006206949A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 1756US2025376518A1Anti-mGluR2 Biparatopic Nanobodies and Uses ThereofUNIV MONTPELLIER·Filed 2023·Application pending·0 cites
- 1855US10287360B2Anti-EGFR conformational single domain antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2015·Granted May 14, 2019·0 cites·13 claims
- 1952US2010151556A1Hybrid and single chain meganucleases and use thereofCELLECTIS·Filed 2009·Application pending·0 cites
- 2050US10174117B2Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancerINST NAT SANTE RECH MED·Filed 2014·Granted Jan 8, 2019·0 cites·16 claims
- 2145US10167345B2Antigen binding formats for use in therapeutic treatments or diagnostic assaysBATY DANIEL·Filed 2017·Granted Jan 1, 2019·0 cites·4 claims
- 2245US9598499B2Antigen binding formats for use in therapeutic treatments or diagnostic assaysBATY DANIEL·Filed 2011·Granted Mar 21, 2017·0 cites·13 claims
- 2339US2014235492A1Methods for preparing single domain antibody microarraysBATY DANIEL·Filed 2011·Application pending·0 cites
- 2437US12187793B2Single-domain antibody binding to the G protein alphaCISBIO BIOASSAYS·Filed 2019·Granted Jan 7, 2025·0 cites·11 claims
- 2537US2018002439A1Anti-mesothelin antibodies and uses thereofINSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE (INSERM)·Filed 2017·Application pending·0 cites
- 2636US2018327499A1Anti- nkg2d single domain antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 2729US10174115B2Anti-mGluR2 conformational single domain antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2015·Granted Jan 8, 2019·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Patrick Chames files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →